Mind Medicine (MindMed) Inc N.MMED.WR

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > $30 up in one day coming

<< Previous

Bullboard Posts

Next >>

Comment by maysteeler23on Feb 10, 2021 8:23pm

229 Views

Post# 32533390

RE:RE:$30 up in one day coming

Shorts were warned with GME, but they didn't learn. 1.5 million new short shares were added from dec 31 2020- jan 15 2021. An increase of 66%.

https://www.marketbeat.com/stocks/OTCMKTS/MMEDF/short-interest/

A total of about 3 million shares were added from dec 2020 -Jan 15. Who knows how much it is now?

You 2x the share price and you wipe about about 3 million short shares. They will have to cover and won't have the money to cover it.

Then you raise the asks to $30 and blast the share price with $500-$1000 after the double. And you cause a short death spiral.

If you're short GET OUT!!! Cause a storm is coming. $30+;)

<< Previous

Bullboard Posts

Next >>

AI companies to invest in